PREDICTING INDIVIDUAL PHENYTOIN SERUM LEVELS OF PATIENTS SEEN IN A PRIVATE OFFICE PRACTICE

被引：5

作者：

ROBINSON, FC ^{[1
]}

WARNER, RN ^{[1
]}

GONZALEZ, MA ^{[1
]}

机构：

[1] PURDUE UNIV,SCH PHARM,W LAFAYETTE,IN 47907

来源：

关键词：

D O I：

10.1212/WNL.31.6.761

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：761 / 763

页数：3

共 9 条

[1]

GERBER N, 1972, RES COMMUN CHEM PATH, V3, P455

[2]

GULEN PJM, 1978, RATIONAL ANTIEPILEPT, P131

[3] INCREASED CLEARANCE OF PHENYTOIN DURING INFECTIOUS-MONONUCLEOSIS [J].

LEPPIK, IE ;

RAMANI, V ;

SAWCHUK, RJ ;

GUMNIT, RJ .

[4]

LUDDEN TM, 1977, CLIN PHARMACOL THER, V21, P287

[5]

LUDDEN TM, 1976, LANCET, V1, P307

[6]

LUND L, 1975, LANCET, V2, P1305

[7] PHENYTOIN DOSE ADJUSTMENT IN EPILEPTIC PATIENTS [J].

MAWER, GE ;

MULLEN, PW ;

RODGERS, M ;

ROBINS, AJ ;

LUCAS, SB .

[8]

PENRY JK, 1978, ANTIEPILEPTIC DRUGS, P1

[9]

RICHENS A, 1975, LANCET, V2, P247